HL logo

Healthlead Public Company LimitedSET:HL Stock Report

Market Cap ฿1.6b
Share Price
฿6.40
Future Cash Flow Value
฿29.3
78.2% undervalued intrinsic discount
1Y-0.8%
7D2.4%
Portfolio Value
​
View

Healthlead Public Company Limited

SET:HL Stock Report

Market Cap: ฿1.6b

Healthlead (HL) Stock Overview

Engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. More details

HL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 78.2% below our estimate of its fair value

Risk Analysis

Unstable dividend track record

Does not have a meaningful market cap (THB2B)


HL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Healthlead Public Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Healthlead
Historical stock prices
Current Share Price฿6.40
52 Week High฿8.45
52 Week Low฿5.40
Beta0.36
1 Month Change-3.76%
3 Month Change-9.86%
1 Year Change-0.78%
3 Year Change-67.84%
5 Year Changen/a
Change since IPO-50.77%

Recent News & Updates

Recent updates

Shareholder Returns

HLTH Consumer RetailingTH Market
7D2.4%-0.5%-1.6%
1Y-0.8%-19.4%30.0%

Return vs Industry: HL exceeded the TH Consumer Retailing industry which returned -19.4% over the past year.

Return vs Market: HL underperformed the TH Market which returned 30% over the past year.

Price Volatility

Is HL's price volatile compared to industry and market?
HL volatility
HL Average Weekly Movement3.0%
Consumer Retailing Industry Average Movement4.2%
Market Average Movement4.9%
10% most volatile stocks in TH Market10.1%
10% least volatile stocks in TH Market2.4%

Stable Share Price: HL has not had significant price volatility in the past 3 months compared to the TH market.

Volatility Over Time: HL's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2018n/aSupakorn Bhandhukanondawww.healthleadgroup.com

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies and devices, as well as disinfectant and deodorizing products, masks, and sterilization products under the iCare, Pharmax, and Super Drug brands; and healthcare product innovations under PRIME, Besuto, and BOMSKIN brands. The company was incorporated in 2018 and is based in Nonthaburi, Thailand.

Healthlead Public Company Limited Fundamentals Summary

How do Healthlead's earnings and revenue compare to its market cap?
HL fundamental statistics
Market cap฿1.64b
Earnings (TTM)฿77.86m
Revenue (TTM)฿2.27b
21.0x
P/E Ratio
0.7x
P/S Ratio

Is HL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HL income statement (TTM)
Revenue฿2.27b
Cost of Revenue฿1.69b
Gross Profit฿583.49m
Other Expenses฿505.63m
Earnings฿77.86m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin25.71%
Net Profit Margin3.43%
Debt/Equity Ratio0%

How did HL perform over the long term?

See historical performance and comparison

Dividends

3.4%
Current Dividend Yield
76%
Payout Ratio

Does HL pay a reliable dividends?

See HL dividend history and benchmarks
When do you need to buy HL by to receive an upcoming dividend?
Healthlead dividend dates
Ex Dividend DateMar 11 2026
Dividend Pay DateMay 15 2026
Days until Ex dividend39 days
Days until Dividend pay date26 days

Does HL pay a reliable dividends?

See HL dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/18 03:07
End of Day Share Price 2026/04/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Healthlead Public Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nuttawut WongyaowalakGloblex Securities Co. Ltd.